Covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease

The incidence and prevalence of inflammatory bowel disease (IBD) are steadily rising worldwide, where the pathogenesis and progression are intrinsically … Continue reading Covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease